fbpx

Reuters: Maryland charges Insys with engaging in deceptive opioid scheme

Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients.

Maryland Attorney General Brian Frosh announced that he had filed administrative charges against Arizona-based Insys, which he said provided thousands of dollars in inducements to doctors to promote prescribing its medication Subsys to their patients.

The company declined comment. It has said that it has taken steps to prevent past mistakes from happening again.

Maryland alleged the company influenced doctors to prescribe the drug beyond its labeled use with inducements that included payments purported to be compensation for participating in educational events.

Read the full article on the Reuters’s website by clicking here.

2018-09-10T19:46:15+00:00